FDA recall, , Moderate risk
Medic Apheresis Red Blood Cells, Leukocytes Reduced
Apheresis Red Blood Cells, Leukocytes Reduced were not tested for hemoglobin and residual white blood cell count as required.
Recall ended Jun 29, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
Medic Inc is recalling Apheresis Red Blood Cells, Leukocytes Reduced because the product was distributed without the required testing for hemoglobin and residual white blood cell count. The recall began on June 27, 2025, and the FDA added it to its Enforcement Report on June 29, 2026. The product was distributed in Tennessee.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Apheresis Red Blood Cells, Leukocytes Reduced
Recall details
- Company began the recall
- Sold in
- Company
- Medic Inc
- Hazard
- Quality testing problem
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99152
- Recall number
- B-0144-2026
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
Archived
